OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at HC Wainwright from $40.00 to $34.00. They now have a "buy" rating on the stock.
HighReport
OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at HC Wainwright from $40.00 to $34.00. They now have a "buy" rating on the stock.
OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $30.00. They now have an "outperform" rating on the stock.
MediumReport
OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $30.00. They now have an "outperform" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: